Yonemoto W, Filson A J, Queral-Lustig A E, Wang J Y, Brugge J S
Mol Cell Biol. 1987 Feb;7(2):905-13. doi: 10.1128/mcb.7.2.905-913.1987.
Cells transformed with the middle tumor antigen (mT) of polyomavirus were treated with sodium orthovanadate (Na3VO4), an inhibitor of phosphotyrosine phosphatases, to enhance for the detection of cellular proteins which are phosphorylated on tyrosine. Na3VO4 treatment of mT-transformed rat F1-11 cells resulted in a 16-fold elevation in the level of phosphotyrosine associated with total cellular proteins. Parental F1-11 cells displayed only a twofold increase in phosphotyrosine following Na3VO4 treatment. The abundance of phosphotyrosine in Na3VO4-treated mT-transformed F1-11 cells was twofold higher than in untreated Rous sarcoma virus (RSV)-transformed F1-11 cells and 3.5-fold lower than in Na3VO4-treated RSV-transformed F1-11 cells. Tyrosine phosphorylation of many cellular proteins, including p36, the major substrate of the RSV pp60v-src protein, was detected in Na3VO4-treated mT-transformed F1-11 cells at levels comparable to those observed in RSV-transformed cells. Some of the major protein species recognized by antiphosphotyrosine antibodies in Na3VO4-treated mT-transformed cells displayed electrophoretic mobilities similar to those detected in RSV-transformed F1-11 cells. Tyrosine phosphorylation of p36 was also detected in fibroblasts infected with polyomavirus. There was no detectable difference in the kinase activity of pp60c-src:mT extracted from untreated and Na3VO4-treated mT-transformed cells; however, Na3VO4 treatment of F1-11 and mT-transformed F1-11 cells was shown to inhibit the activity of phosphotyrosine phosphatases in a crude assay of total cellular activity with pp60v-src as the substrate. Thus, Na3VO4 treatment may allow the detection of phosphotyrosine-containing proteins in mT-transformed cells by preventing the turnover of phosphate on substrates phosphorylated by activated cellular protein-tyrosine kinases associated with mT. These results suggest that tyrosine phosphorylation of cellular proteins may be involved in the events that are responsible for mT-induced cellular transformation.
用多瘤病毒的中间肿瘤抗原(mT)转化的细胞用原钒酸钠(Na3VO4)处理,原钒酸钠是一种磷酸酪氨酸磷酸酶抑制剂,用于增强对酪氨酸磷酸化的细胞蛋白的检测。用Na3VO4处理mT转化的大鼠F1-11细胞导致与总细胞蛋白相关的磷酸酪氨酸水平升高16倍。亲本F1-11细胞在Na3VO4处理后磷酸酪氨酸仅增加两倍。在经Na3VO4处理的mT转化的F1-11细胞中,磷酸酪氨酸的丰度比未处理的劳斯肉瘤病毒(RSV)转化的F1-11细胞高两倍,比经Na3VO4处理的RSV转化的F1-11细胞低3.5倍。在经Na3VO4处理的mT转化的F1-11细胞中检测到许多细胞蛋白的酪氨酸磷酸化,包括RSV pp60v-src蛋白的主要底物p36,其水平与在RSV转化的细胞中观察到的水平相当。在经Na3VO4处理的mT转化细胞中,抗磷酸酪氨酸抗体识别的一些主要蛋白种类显示出与在RSV转化的F1-11细胞中检测到的电泳迁移率相似。在感染多瘤病毒的成纤维细胞中也检测到p36的酪氨酸磷酸化。从未处理和经Na3VO4处理的mT转化细胞中提取的pp60c-src:mT的激酶活性没有可检测到的差异;然而,在以pp60v-src为底物的总细胞活性的粗测定中,Na3VO4处理F1-11和mT转化的F1-11细胞显示出抑制磷酸酪氨酸磷酸酶的活性。因此,Na3VO4处理可能通过防止与mT相关的活化细胞蛋白酪氨酸激酶磷酸化的底物上的磷酸盐周转,从而检测mT转化细胞中含磷酸酪氨酸的蛋白。这些结果表明,细胞蛋白的酪氨酸磷酸化可能参与了导致mT诱导细胞转化的事件。